Back to Avoro Capital Advisors LLC
Q2 2026 13F filing
Updated 27 days ago26 disclosed positions worth $11.1B
Portfolio value
$11.1B
Total holdings
26
New positions
0
Closed positions
0
Increased
0
Decreased
0
Turnover
—
Filed
2026-08-14
Full holdings
Every line item disclosed in Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | U UTHR UNITED THERAPEUTICS CORP | $1.5B | 2.78M | 13.52% | — |
| 2 | A ASND ASCENDIS PHARMA | $1.4B | 5.11M | 12.24% | — |
| 3 | K KRYS KRYSTAL BIOTECH INC | $1.1B | 2.89M | 9.64% | — |
| 4 | M MDGL MADRIGAL PHARMACEUTICALS INC | $984.4M | 1.83M | 8.84% | — |
| 5 | A ARGX ARGENX SE | $927.8M | 1.00M | 8.33% | — |
| 6 | A ARWR ARROWHEAD PHARMACEUTICALS INC | $925.6M | 11.36M | 8.31% | — |
| 7 | K KYMR KYMERA THERAPEUTICS INC | $857.1M | 7.47M | 7.70% | — |
| 8 | R RVMDW REVOLUTION MEDICINES INC | $430.2M | 2.30M | 3.86% | — |
| 9 | C CYTK CYTOKINETICS INC | $425.9M | 5.00M | 3.82% | — |
| 10 | C CELC CELCUITY INC | $355.7M | 3.40M | 3.19% | — |
| 11 | G GPCR STRUCTURE THERAPEUTICS INC | $351.8M | 6.56M | 3.16% | — |
| 12 | X XENE XENON PHARMACEUTICALS INC | $348.7M | 5.78M | 3.13% | — |
| 13 | D DFTX DEFINIUM THERAPEUTICS INC | $338.2M | 7.19M | 3.04% | — |
| 14 | Q QURE UNIQURE NV | $309.9M | 6.73M | 2.78% | — |
| 15 | V VERA VERA THERAPEUTICS INC | $245.6M | 5.72M | 2.21% | — |
| 16 | T TSHA TAYSHA GENE THERAPIES INC | $162.7M | 23.89M | 1.46% | — |
| 17 | O OCFC OCULAR THERAPEUTIX INC | $123.1M | 12.54M | 1.11% | — |
| 18 | ? N/A DAMORA THERAPEUTICS INC | $98.4M | 3.78M | 0.88% | — |
| 19 | C COAG HEMAB THERAPEUTICS HLDGS INC | $70.7M | 1.93M | 0.64% | — |
| 20 | G GHRS GH RESEARCH PLC | $48.4M | 1.80M | 0.43% | — |
| 21 | V VRDN VIRIDIAN THERAPEUTICS INC | $45.9M | 2.50M | 0.41% | — |
| 22 | S SEPN SEPTERNA INC | $44.8M | 1.34M | 0.40% | — |
| 23 | A AVTX AVALO THERAPEUTICS | $43.1M | 2.33M | 0.39% | — |
| 24 | F FTH FAETH THERAPEUTICS INC | $36.1M | 1.44M | 0.32% | — |
| 25 | ? N/A WHITEHAWK THERAPEUTICS INC | $13.1M | 2.85M | 0.12% | — |
| 26 | ? N/A LEXEO THERAPEUTICS INC | $6.9M | 1.49M | 0.06% | — |